Talis Biomedical Corporation (TLIS)
OTCMKTS
· Delayed Price · Currency is USD
1.665
0.00 (0.00%)
Feb 5, 2025, 4:00 PM EST
Talis Biomedical Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
| Cash & Equivalents | 59.87 | 76.73 | 130.19 | 232.55 | 138.48 | 21.6 | Upgrade
|
| Cash & Short-Term Investments | 59.87 | 76.73 | 130.19 | 232.55 | 138.48 | 21.6 | Upgrade
|
| Cash Growth | -39.04% | -41.06% | -44.01% | 67.92% | 541.01% | 213.33% | Upgrade
|
| Receivables | - | 0.05 | 0.31 | 0.18 | 0.47 | 1.81 | Upgrade
|
| Prepaid Expenses | 3.73 | 0.9 | 2.78 | 3.39 | 0.71 | 0.43 | Upgrade
|
| Restricted Cash | - | - | - | - | 34.65 | - | Upgrade
|
| Other Current Assets | - | - | - | - | 14.41 | 0.27 | Upgrade
|
| Total Current Assets | 63.6 | 77.68 | 133.28 | 236.12 | 188.72 | 24.11 | Upgrade
|
| Property, Plant & Equipment | 8.33 | 15.45 | 34.23 | 23.44 | 9.68 | 1.54 | Upgrade
|
| Other Long-Term Assets | 0.77 | 1.54 | 1.78 | 6.28 | - | 0.09 | Upgrade
|
| Total Assets | 72.7 | 94.67 | 169.29 | 265.83 | 198.41 | 25.73 | Upgrade
|
| Accounts Payable | 3.79 | 1.34 | 3.77 | 5.12 | 4.91 | 1.57 | Upgrade
|
| Accrued Expenses | 1.48 | 4.55 | 5.2 | 12.75 | 10.43 | 2.13 | Upgrade
|
| Current Portion of Leases | 2.92 | 2.88 | 3.7 | 1.23 | 0.69 | - | Upgrade
|
| Other Current Liabilities | - | - | - | - | - | 0.34 | Upgrade
|
| Total Current Liabilities | 8.2 | 8.77 | 12.67 | 19.11 | 16.03 | 4.04 | Upgrade
|
| Long-Term Leases | 15.88 | 16.79 | 29.88 | 12.75 | - | - | Upgrade
|
| Other Long-Term Liabilities | - | - | - | - | - | 0.08 | Upgrade
|
| Total Liabilities | 24.07 | 25.56 | 42.55 | 31.85 | 16.03 | 4.12 | Upgrade
|
| Common Stock | - | - | - | 0 | - | - | Upgrade
|
| Additional Paid-In Capital | 610.47 | 609.07 | 604.69 | 598.91 | 64.34 | 60.64 | Upgrade
|
| Retained Earnings | -561.85 | -539.96 | -477.95 | -364.94 | -172.91 | -81.78 | Upgrade
|
| Total Common Equity | 48.62 | 69.11 | 126.74 | 233.97 | -108.57 | -21.14 | Upgrade
|
| Shareholders' Equity | 48.63 | 69.12 | 126.74 | 233.98 | 182.37 | 21.62 | Upgrade
|
| Total Liabilities & Equity | 72.7 | 94.67 | 169.29 | 265.83 | 198.41 | 25.73 | Upgrade
|
| Total Debt | 18.8 | 19.67 | 33.58 | 13.98 | 0.69 | - | Upgrade
|
| Net Cash (Debt) | 41.07 | 57.06 | 96.61 | 218.57 | 137.79 | 21.6 | Upgrade
|
| Net Cash Growth | -47.23% | -40.93% | -55.80% | 58.62% | 537.80% | 213.33% | Upgrade
|
| Net Cash Per Share | 22.55 | 31.40 | 53.66 | 144.71 | 974.78 | 150.68 | Upgrade
|
| Filing Date Shares Outstanding | 1.82 | 1.82 | 1.79 | 1.78 | 1.71 | 0.14 | Upgrade
|
| Total Common Shares Outstanding | 1.82 | 1.82 | 1.79 | 1.76 | 0.14 | 0.14 | Upgrade
|
| Working Capital | 55.41 | 68.91 | 120.61 | 217.01 | 172.69 | 20.07 | Upgrade
|
| Book Value Per Share | 26.68 | 37.93 | 70.95 | 132.90 | -765.93 | -149.89 | Upgrade
|
| Tangible Book Value | 48.62 | 69.11 | 126.74 | 233.97 | -108.57 | -21.14 | Upgrade
|
| Tangible Book Value Per Share | 26.68 | 37.93 | 70.95 | 132.90 | -765.93 | -149.89 | Upgrade
|
| Machinery | - | 14.72 | 13.9 | 8.99 | 4.72 | 2.96 | Upgrade
|
| Construction In Progress | - | - | 0.98 | 4.72 | 6.58 | - | Upgrade
|
| Leasehold Improvements | - | 1.25 | 1.25 | 0.81 | 0.81 | 0.81 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.